Connection

Jacqueline Kraveka to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Jacqueline Kraveka has written about Antibodies, Monoclonal, Humanized.
Jacqueline Kraveka
Connection Strength
0.049
Antibodies, Monoclonal, Humanized
  1. A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma. Clin Cancer Res. 2022 09 15; 28(18):3950-3957.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.